lycorine has been researched along with podophyllotoxin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksenov, AV; Brenner, AJ; Cavazos, DA; Cencic, R; Dasari, R; Evidente, A; Frolova, LV; Henry, S; Kidner, R; Kiss, R; Kornienko, A; Lefranc, F; Ma, X; Magedov, IV; Mathieu, V; Pelletier, J; Pertsemlidis, A; Reisenauer, MR; Rogelj, S; Yu, X | 1 |
| Nair, JJ; van Staden, J | 1 |
1 review(s) available for lycorine and podophyllotoxin
| Article | Year |
|---|---|
Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.
Topics: Amaryllidaceae; Amaryllidaceae Alkaloids; Antiprotozoal Agents; Diterpenes; Drug Evaluation, Preclinical; Humans; Isoquinolines; Molecular Structure; Phytochemicals; Plant Extracts; Structure-Activity Relationship; Trypanosoma brucei brucei | 2019 |
1 other study(ies) available for lycorine and podophyllotoxin
| Article | Year |
|---|---|
5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells.
Topics: Amaryllidaceae; Amaryllidaceae Alkaloids; Antineoplastic Agents; Drug Resistance, Neoplasm; Humans; Plant Extracts; Tumor Cells, Cultured | 2016 |